Brief: Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase Agreement
Oct 17 (Reuters) - XOMA ROYALTY: XOMA ROYALTY AND LAVA THERAPEUTICS ANNOUNCE AMENDMENT TO PURCHASE AGREEMENT XOMA ROYALTY CORP: LAVA SHAREHOLDERS WHO TENDER THEIR SHARES WILL NOW RECEIVE AN INITIAL CASH AMOUNT PER SHARE OF $1.04 XOMA ROYALTY CORP: AMENDMENT TO AGREEMENT WITH LAVA INCLUDES UPDATED CVR TERMS FOR TENDER OFFER Source text: ID:nGNX8lKj3Z Further company coverage: XOMA.OLVTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xoma Royalty
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM